# A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia

> **NCT00696787** · PHASE2 · TERMINATED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 125 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Desvenlafaxine Sustained Release (DVS SR)
- **DRUG:** Lyrica® (Pregabalin)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00696787
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2013-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696787, "A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00696787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*